Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|May 6, 2025
Navigating Pharmacogenomic Testing in Practice: Who to Test and When to TestJames M Stevenson, D Max Smith, Sony Tuteja, et al.Pharmacogenomics|October 17, 2019
Activation of HCAR2 by niacin: benefits beyond lipid loweringSony TutejaClinical Pharmacology and Therapeutics|January 31, 2025
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical PracticeTeresa T Ho, D Max Smith, Christina L Aquilante, et al.Current Genetic Medicine Reports|October 24, 2017
Pharmacogenetics in Cardiovascular MedicineSony Tuteja, Nita LimdiClinical Pharmacology and Therapeutics|June 23, 2023
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine ChemotherapyDaniel L Hertz, D Max Smith, Stuart A Scott, et al.Nature Reviews. Endocrinology|September 3, 2014
Dyslipidaemia: cardiovascular prevention--end of the road for niacin?Sony Tuteja, Daniel J RaderCirculation. Genomic and Precision Medicine|August 30, 2019
Gut Microbiome and Response to Cardiovascular DrugsSony Tuteja, Jane F FergusonPersonalized Medicine|May 20, 2018
Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular diseaseSony Tuteja, Daniel J RaderClinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.Pharmacogenomics|December 17, 2013
Application of genotype-guided cancer therapy in solid tumorsJai N PatelPageof 19